Samuel Adams, MD
Orthopaedic Surgery of the Spine · Soldotna, AKNPI 1306285630
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $13,183 of the $17,224 with a category attached, or 76.5%. Stryker accounts for 70.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $5,303 and has fallen 94.2% since, to $306 in 2025.
Across 143 payments — averaging $120.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$12K
- Medtronic$3K
- Globus Medical$1K
- Johnson & Johnson$408
- VB Spine LLC$207
- CTL Medical Corporation$15
- plus $11 from 1 others
What the payments were for
- Travel & lodging$13,18377%
- Food & beverage$4,04123%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 90 | $12,060 |
| Medtronic(2 entities) | 26 | $3,473 |
| Globus Medical(2 entities) | 7 | $1,050 |
| Johnson & Johnson(2 entities) | 14 | $408 |
| VB Spine LLC | 4 | $207 |
| CTL Medical Corporation | 1 | $15 |
| Avanos Medical | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVEREST SPINAL SYSTEM$5,462
- SERRATO$2,222
- CD HORIZON SPINAL SYSTEM$1,166
- Excelsius - GPS$915
- AERO-LL$751
- MAZOR X SYSTEM$744
- ProLift$509
- PROstep$465
- AUGMENT INJECTABLE$465
- INFINITY$465
- SALVATION$465
- ORTHOLOC 2 LAPIFUSE$465
- O-ARM-ST$463
- MazorX - Renaissance$437
- TRITANIUM$255
- RAVINE LATERAL ACCESS SYSTEM$172
How this compares
Too few orthopaedic surgery of the spine providers in Alaskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 38 | $433 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $172 |
| Meloxicam | 11 | $90 |
| Tramadol Hcl | 37 | $87 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $51 |
| Cyclobenzaprine Hcl | 18 | $42 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Soldotna
- Steven HumphreysSoldotna$199K
- John AndreshakSoldotna$22K
- Stewart KerrFairbanks$51K
- Iain ElliottAnchorage$30K
- James EuleAnchorage$17K
- Derrick FogeAnchorage$7K
- Gene FalkowskiAnchorage$5K
- Upshur SpencerAnchorage$4K
- Brent AdcoxHomer$4K
- Mark FlanumAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.